Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2024 Earnings Call Transcript

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2024 Earnings Call Transcript February 25, 2025

Ginkgo Bioworks Holdings, Inc. misses on earnings expectations. Reported EPS is $-2 EPS, expectations were $-1.45.

Joseph Fridman : Good evening. I’m Joseph Fridman, Director of Communications and Corporate Affairs here at Ginkgo, where it’s my fifth year. During that time, I’ve had the pleasure and the privilege of working with our Investor Relations team. usually behind the scenes of these earnings...